Hematopoietic stem cell transplantation for diffuse large B‐cell lymphoma having 8q24/ MYC rearrangement in Japan-Reference-Cited by-同舟云学术

Hematopoietic stem cell transplantation for diffuse large B‐cell lymphoma having 8q24/ MYC rearrangement in Japan

Published:2020-10-05 Issue:1 Volume:39 Page:66-74
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Takahashi Tsutomu¹²^ORCID,Suzuki Ritsuro¹²,Yamamoto Go³,Nakazawa Hideyuki⁴,Kurosawa Mitsutoshi⁵,Kobayashi Tsutomu⁶,Okada Masaya⁷,Akasaka Takashi⁸,Kim Sung‐Won⁹,Fukuda Takahiro⁹,Ichinohe Tatsuo¹⁰,Atsuta Yoshiko¹¹¹²,Suzumiya Junji¹²

Affiliation:

1. Department of Oncology/Hematology Shimane University Hospital Izumo Japan

2. The Adult Malignant Lymphoma Working Group of the JSHCT Nagoya Japan

3. Department of Hematology Toranomon Hospital Tokyo Japan

4. Division of Hematology Department of Internal Medicine Shinshu University School of Medicine Matsumoto Japan

5. Department of Hematology National Hospital Organization Hokkaido Cancer Center Sapporo Japan

6. Division of Hematology and Oncology Department of Medicine Kyoto Prefectural University of Medicine Kyoto Japan

7. Division of Hematology Department of Internal Medicine Hyogo College of Medicine Nishinomiya Japan

8. Department of Hematology Tenri Hospital Tenri Japan

9. Department of Hematopoietic Stem Cell Transplantation National Cancer Center Hospital Tokyo Japan

10. Department of Hematology and Oncology Research Institute for Radiation Biology and Medicine Hiroshima University Hiroshima Japan

11. Japanese Data Center for Hematopoietic Cell Transplantation Nagoya Japan

12. Department of Healthcare Administration Nagoya University Graduate School of Medicine Nagoya Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2811

Reference40 articles.

1. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.

2. Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)

3. MYCtranslocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type

4. Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of autograft-absolute lymphocyte count on survival in double/triple hit lymphomas post-autologous stem cell transplantation;Leukemia & Lymphoma;2022-04-28

2. Modified conditioning regimen with chidamide and high‐dose rituximab for triple‐hit lymphoma;Journal of Cellular and Molecular Medicine;2021-10-25